1] Center for Life Nano Science@Sapienza, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161 Rome, Italy [2].
1] Department of Biology and Biotechnology Charles Darwin and IBPM, Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, Italy [2].
Nat Commun. 2014 Jul 9;5:4335. doi: 10.1038/ncomms5335.
While the physiologic functions of the RNA-binding protein FUS still await thorough characterization, the pathonegetic role of FUS mutations in amyotrophic lateral sclerosis (ALS) is clearly established. Here we find that a human FUS mutation that leads to increased protein expression, and was identified in two ALS patients with severe outcome, maps to the seed sequence recognized by miR-141 and miR-200a in the 3'-UTR of FUS. We demonstrate that FUS and these microRNAs are linked by a feed-forward regulatory loop where FUS upregulates miR-141/200a, which in turn impact FUS protein synthesis. We also show that Zeb1, a target of miR-141/200a and transcriptional repressor of these two microRNAs, is part of the circuitry and reinforces it. Our results reveal a possible correlation between deregulation of this regulatory circuit and ALS pathogenesis, and open interesting perspectives in the treatment of these mutations through ad hoc-modified microRNAs.
虽然 RNA 结合蛋白 FUS 的生理功能仍有待全面描述,但 FUS 突变在肌萎缩侧索硬化症(ALS)中的致病作用已得到明确证实。在这里,我们发现一种导致蛋白表达增加的人类 FUS 突变,该突变存在于两名预后严重的 ALS 患者中,定位于 FUS 3'-UTR 中 miR-141 和 miR-200a 识别的种子序列。我们证明 FUS 和这些 microRNAs 之间存在正反馈调控环,其中 FUS 上调 miR-141/200a,而后者又影响 FUS 蛋白合成。我们还表明,Zeb1 是 miR-141/200a 的靶标,也是这两种 microRNAs 的转录抑制因子,是该回路的一部分,并对其进行强化。我们的研究结果揭示了该调控回路失调与 ALS 发病机制之间可能存在的相关性,并为通过特定修饰的 microRNAs 治疗这些突变提供了有趣的前景。